Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial...

by Dumbleton, J., Fitzmaurice, D., Fraser, S.D, Fuat, A., Gallagher, H., Griffith, K.E, Hawkey, C.J, Henderson, R.A, Lord, J., Lown, M., Maishman, T., Moore, M.V, Roderick, P.J, Stevens, P., Stevenson, D., Taal, M.W, Whitehead, A.
Published 2022